Compare Remala Abadi Tbk. (DATA) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Remala Abadi Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Remala Abadi Tbk. trades at Rp1,890 (market cap 2.64T, 655.7K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp242 (market cap 164.65B, 187.4K 24h volume). The key difference: Remala Abadi Tbk. is far larger — about 16× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Remala Abadi Tbk. is more actively traded (655.7K versus 187.4K). Which is the better fit depends on your goals.
| DATA | OBAT | |
|---|---|---|
Market Cap | 2.64T | 164.65B |
Volume | 655.7K | 187.4K |
Lot | 6.56K | 1.87K |
Turnover | 1.24B | 44.35M |
Average Price | 1,885.23 | 236.67 |
Value | 1.24B | 44.35M |
Indicative Equilibrium Price | 1,890 | 242 |
Indicative Equilibrium Volume | 116 | 500 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Remala Abadi Tbk.
PT. Remala Abadi Tbk (the Company) was established based on Deed No.5, dated March 15, 2004 made before Notary Fajra Rizqi Nasution, SH. The company started its commercial activities since 2004.
Read more on DATA →About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →
